ITUS Corporation (NYSE:ANIX) shares shot up 3.8% during trading on Friday . The stock traded as high as $4.11 and last traded at $4.11, 535 shares were traded during mid-day trading. A decline of 99% from the average session volume of 65,478 shares. The stock had previously closed at $3.96.

Separately, Zacks Investment Research upgraded shares of ITUS from a “hold” rating to a “buy” rating and set a $5.25 price objective for the company in a report on Tuesday, July 30th.

The company’s fifty day simple moving average is $4.28 and its 200 day simple moving average is $4.34.

ITUS (NYSE:ANIX) last issued its quarterly earnings data on Tuesday, June 11th. The company reported ($0.13) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.23) by $0.10. The company had revenue of $0.25 million during the quarter.

About ITUS (NYSE:ANIX)

Anixa Biosciences, Inc engages in the development, acquisition and licensing emerging technology in the field of biotechnology. It focuses on platform called Cchek, a series of inexpensive non-invasive blood tests for the early detection of cancer, which is based on the body’s immunological response to the presence of a malignancy.

Further Reading: What does a bar chart display?

Receive News & Ratings for ITUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ITUS and related companies with MarketBeat.com's FREE daily email newsletter.